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INTRODUCTION
Stiff Person Syndrome (SPS) is a rare autoimmune
based neurological disease characterised by rigidity and
painful spastic episodes primarily involving the muscles
of abdomen, spine and lower limb.1 The reported
incidence of the disease is 1:1,000,000 and patients
usually presents in 4th decade of their life. The disease
is more common in females than males with 2:1 ratio.2
The diagnosis of the disease is often delayed due to its
rarity and non-specific signs and symptoms. Muscle
spasms associated with the disease are very debilitating
and fluctuating in severity and timing. These spasms
may occur spontaneously or triggered by pain, anxiety
and contact with the unusual surface or loud noises.2
The primary pathology is the presence of autoantibodies
against glutamic acid decarboxylase 65 isoenzyme
(GAD 65) and positive serology is not required for the
diagnosis.3 Glutamic acid decarboxylase (GAD) is
responsible for the last rate limiting step in the synthesis
of gamma-aminobutyric acid (GABA). Due to loss of
inhibition by GABA, there is chronic activation of motor
neurons causing muscle contractions leading to muscle
spasm and rigidity. SPS is also associated with other
autoimmune disease like thyroiditis, diabetes mellitus,
etc.4
Presently, there is no cure for the disease but the main
management relies on enhancing the GABA receptors
by targeting the GABAB through baclofen therapy.Multimodal analgesia can be used to relieve the pain.
Corticosteroids, intravenous immunoglobulins and
plasmapheresis can be helpful in modulating the
disease process.5 The anesthetic implications of SPS
have been infrequently reported. Due to some
anesthetic medications interacting with GABA receptors,
anesthesia in SPS patients requires special attention.
We describe the management of SPS patient for total
hip replacement under spinal anesthesia.
CASE REPORT
A 53-year male with height of 158 cm and weight of
65 kg, known case of SPS, was admitted to hospital with
the complaint of shortening of right leg for 4 months and
was planned for total hip replacement by orthopedic
team. Actually, he was admitted in the hospital with the
diagnosis of community acquired pneumonia 6 months
ago. During that stay, he sustained the right femoral
intertrochanteric fracture, which he noticed after the
discharge from hospital as shortening of right limb at
home. Patient then waited for some time as he was
recovering from pneumonia and then consulted the
orthopedic surgeon. Past surgical history was not
significant.
He was diagnosed as a case of SPS by the neurology
team about 5 years ago from the current admission. He
had significant lower limb muscle spasm with history of
multiple falls. He had to take help from family members
to carry out routine activities and was unable to perform
fine motor skills. He developed muscle contractures over
the period of 2 to 3 years, which greatly impaired his
mobility. He was functional class III. Patient was treated
with Intravenous immunoglobulins but no remarkable
improvement was noted. Currently, in this admission, he
was on oral medications baclofen, tizanidine, clonazepam
and gabapentin.
Physical examination of the patient revealed spasticity of
lower limb along with the involvement of spinal muscles.
Motor strength was fine in all four limbs along with
reflexes. Electromyography (EMG) and electroencephalo-
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graphy were done and were normal. GAD6 autoanti-
bodies levels were high. Mallampati grade of airway
examination was II with normal thyromental distance.
Laboratory data was within normal limits. Echocardio-
graphy (ECG) was done which showed normal ejection
fraction with grade I left ventricular dysfunction.
A very detailed discussion was carried out by the
anesthesia, orthopedics and neurology team. After
thorough evaluation and workup, details were discussed
with the patient and spinal anesthesia was planned for
the procedure. General anesthesia was avoided as
patient was already on muscle relaxants, so general
anesthesia could have potentiated their effects in the
form of delayed recovery. Standard monitoring was
applied before performing the spinal anesthesia.
Midazolam and ketamine was used to sedate the
patient, so the left lateral position can be made for the
procedure. The most difficult part was to position the
patient for spinal anesthesia. Due to the involvement of
the back muscles, it was very hard to make the right
lateral position of the patient. After standard precautions,
25G cutting needle was introduced at the level of L3 and
L4 after the local infiltration of the skin with 2% lidocaine.
After 3 attempts, free flow of cerebrospinal fluid (CSF)
was achieved and 10mg hyperbaric bupivacaine and
25 µg fentanyl was injected in the CSF. It took about
45 minutes to position the patient and perform the spinal
anesthesia. He remained hemodynamically stable after
the spinal anesthesia. We also started the propofol
infusion for the sedation of the patient. Midway during
the procedure, orthopedic team had a bit difficulty in
reducing the femur head. The smallest possible size of
the femur head was tried but unsuccessful. To facilitate
the surgeons, we switched off the propofol sedation and
started inhalational agent sevoflurane through face
mask. Surgery team was then able to reduce the femur
head. After reduction of femur head, we again started
propofol infusion. Patient remained vitally stable
throughout the procedure. Intraoperative blood loss was
around 550ml and urine output remained around
0.5ml/kg/hour. After the procedure, patient was shifted to
recovery room. Postoperative pain was managed by
multimodal analgesia involving patient controlled
intravenous analgesia (PCIA) tramadol, paracetamol
and ketorolac. Patient was mobilised the very next day
and was discharged on 5th postoperative day.
DISCUSSION
Due to extremely low incidence of the disease, limited
data is available on the anesthetic management of
patient with SPS.6 We used spinal anesthesia
(bupivacaine and fentanyl) for total hip replacement
because general anesthesia might have been
associated with delayed emergence and recovery. This
technique provides suitable condition for the surgery.
Epidural anesthesia has been used in SPS patient for
urgent cesarean-section successfully.2 In patients with
SPS, there is conflicting evidence on the use of muscle
relaxants. In a case report by Obara et al., the use of
vecoronium in a diagnosed case of SPS for thymectomy,
six week later for emergency appendectomy and one
year later for endoscopic nasal sinus surgery had no
adverse effect and 25% twitch recovery time was within
normal limit.7 However, contradictory to this, in a case
report by Johnson and Miller, patient was mechanically
ventilated overnight due to significant residual muscle
weakness in spite of the presence of all four twitches
of train of four (TOF) at the end of surgery and reversal
of neuromuscular blockade of vecoronium with
neostigmine and glycopyrrolate.8 In a similar report by
Ferrandis et al. of a patient of SPS undergoing cardiac
surgery receiving pancuronium, the patient had normal
return of TOF after the first dose of pancuronium but
delayed recovery.9 In a study by Bouw et al., there was
normal return of TOF but patient was ventilated for long
time due to residual muscle weakness.10 The muscle
relaxants might not be the cause of residual muscle
weakness after the general anesthesia. It might be the
interaction between the volatile anesthetics and GABA
receptors in the central nervous system leading to
muscle weakness in these group of patients. The lack of
objective evidence of muscle weakness in these patients
is the primary reason to be cautious while administrating
any type of anesthesia. The proposed hypothesis of
prolonged weakness after general anesthesia is the
interaction of volatile anesthetics and baclofen on GABA
receptors have been documented in literature.11
Neuraxial stiffness and lumbar lordosis due to muscle
spasm makes central neuraxial block difficult to perform
in SPS patients. We used moderate sedation to perform
spinal anesthesia as pain can exacerbate the muscle
spasm in such patients. It is still debatable which
anesthetic technique is safe for SPS patients. As for
most rare diseases, multidisciplinary team and patient
involvement can lead to the best possible outcome.
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